17 studies found for:
Lennox-Gastaut Syndrome
Display Options
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Not yet recruiting |
Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects
|
||||
| 2 |
Completed
Has Results |
Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome
|
||||
| 3 | Completed |
A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients
|
||||
| 4 | Recruiting |
Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs
|
||||
| 5 | Completed |
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome
|
||||
| 6 |
Completed
Has Results |
Clobazam in Patients With Lennox-Gastaut Syndrome
|
||||
| 7 | Completed |
A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome
|
||||
| 8 |
Completed
Has Results |
Clobazam in Subjects With Lennox-Gastaut Syndrome
|
||||
| 9 | Completed |
Ketogenic Diet for Child Epilepsy and Seizure Control
|
||||
| 10 | Completed |
A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures
|
||||
| 11 | Recruiting |
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
||||
| 12 | Active, not recruiting |
Epilepsy Phenome/Genome Project
|
||||
| 13 | Active, not recruiting |
A Long Term Extension Study of E2080 in Lennox-Gastaut Patients
|
||||
| 14 | Completed |
Study in Pediatric Subjects With Epilepsy
|
||||
| 15 | Completed |
Metabolic Abnormalities in Children With Epilepsy
|
||||
| 16 | Completed |
A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures
|
||||
| 17 | Completed |
Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder
|
† Indicates status has not been verified in more than two years